Patent Number: 6,512,099

Title: Roselipin derivative

Abstract: Roselipin derivatives which are represented by the following formula: ##STR1## [wherein R.sup.1 represents a hydrogen atom, mannose or acetylated mannose, R.sup.2 represents a hydrogen atom or a methyl group, and R.sup.3 represents a methyl group or a sugar alcohol], excluding a compound in which R.sup.1 is mannose, R.sup.2 is a hydrogen atom and R.sup.3 is arabinitol (roselipin 1A or 1B) and a compound in which R.sup.1 is acetylated mannose, R.sup.2 is a hydrogen atom and R.sup.3 is arabinitol (roselipin 2A or 2B), and which are useful for preventing and treating a disease of a human which is caused by accumulation of triacylglycerol can be obtained.

Inventors: Omura; Satoshi (Minato-ku, JP), Tomoda; Hiroshi (Minato-ku, JP)

Assignee: Kitasato Institute

International Classification: C07C 69/00 (20060101); C07C 69/732 (20060101); C07H 13/06 (20060101); C07H 15/00 (20060101); C07H 13/00 (20060101); C07H 15/10 (20060101); C07G 011/00 (); C07G 003/00 (); C07H 015/00 (); C07H 017/00 ()

Expiration Date: 01/28/2020